Humedix Co., Ltd. is a company specializing in Hyaluronic Acid (HA) and Core source technology for the production and application development of polydeoxyribo nucleotide (PDRN) raw materials. Founded in 2003, the company aims to expand its business area to the field of aesthetics and specialized biopharmaceuticals. Their main products include hyaluronic acid filler "Elavier Premier," aesthetic medical device "Derma Shine," high-performance cosmetics, type A botulinum toxin "Riztox," hyaluronic acid single-dose formulation arthritis injection "Hi Hyal Once," and PDRN injection "Livitalex." Humedix focuses on continuous research and development to develop new materials in healthcare and strives to develop high-value-added products to gain customer trust. The company also aims to strengthen its partnership with global biotechnology companies to become a global healthcare company.
Headquarters
268603,Hagui-Ro, Dongan-Gu
Anyang; Gyeonggi;
Contact Details: Purchase the Humedix Co., Ltd. report to view the information.
Website: http://www.humedix.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service